de los Pinos Elisabet 4

What Happened
Elisabet de los Pinos, President and Chief Executive Officer of Aura Biosciences (AURA), disposed of 47,648 shares on 2026-02-17 in a sale reporting a weighted-average price of $5.06, for an aggregate value of approximately $241,099. The filing indicates the sale was automatic to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not a discretionary open-market decision.

Key Details

• Transaction date: 2026-02-17
• Transaction type/code: Sale (S); reported as tax-withholding disposition (footnote F1 / code F)
• Price: weighted average $5.06; shares were sold across prices ranging $5.04 to $5.26 (footnote F2)
• Shares disposed: 47,648; aggregate proceeds ≈ $241,099
• Shares held/vehicle: Shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016; Reporting Person is a trustee (footnote F3)
• Ownership after transaction: Not specified in the provided filing excerpt
• Filing timeliness: Reported on 2026-02-17 with a Period of Report 2026-02-17 — no late filing indicated

Context
Sales to cover tax withholding for RSU vesting are routine administrative transactions and do not necessarily reflect the insider’s view of the company. For retail investors, purchases typically carry more informative weight about insider sentiment; this filing documents a tax-related, automatic sale rather than a voluntary liquidation.